Home Trending
MDMA Treatments Found to Eliminate PTSD Symptoms in Phase II Trial
According to a study published by clinical neuroscience in 2000, statistically, each person has a 50 percent chance of experiencing…
How Whole Systems Thinking Could Transform the Clinical Supply Chain
In 2006, the United States Government Accountability Office (US GAO) issued a report, GAO-07-49, highlighting historical attrition rates in drug…
Managing Blinding Requirements in IRT: An Overview
Global clinical trends show an increasing level of complexity in trial design, adding critical challenges on randomization and information blinding.…
Integrating New Assets: A Supply Chain Perspective
The competitive landscape for biopharmaceuticals always seems to be heating up. Internally developed assets are rarely enough to sustain growth,…
Observations from GCP Sponsor Inspections
When it comes to GCP sponsor inspections there are numerous agencies throughout the world that may review your organizational practices.…